Terms: = Adult Hodgkin lymphoma AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Staging
31 results:
1. hodgkin lymphoma: hypodense lesions in mediastinal masses.
Damek A; Kurch L; Franke FC; Attarbaschi A; Beishuizen A; Cepelova M; Ceppi F; Daw S; Dieckmann K; Fernández-Teijeiro A; Feuchtinger T; Flerlage JE; Fosså A; Georgi TW; Hasenclever D; Hraskova A; Karlen J; Klekawka T; Kluge R; Körholz D; Landman-Parker J; Leblanc T; Mauz-Körholz C; Metzler M; Pears J; Steglich J; Uyttebroeck A; Vordermark D; Wallace WH; Wohlgemuth WA; Stoevesandt D
Sci Rep; 2024 Jun; 14(1):14591. PubMed ID: 38918503
[TBL] [Abstract] [Full Text] [Related]
2. Update on FDG-PET in pediatric lymphoma.
Kurch L; Kluge R
Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):58-69. PubMed ID: 38587361
[TBL] [Abstract] [Full Text] [Related]
3. Pulmonary lesions in early response assessment in pediatric hodgkin lymphoma: prevalence and possible implications for initial staging.
Stoevesandt D; Ludwig C; Mauz-Körholz C; Körholz D; Hasenclever D; McCarten K; Flerlage JE; Kurch L; Wohlgemuth WA; Landman-Parker J; Wallace WH; Fosså A; Vordermark D; Karlén J; Cepelová M; Klekawka T; Attarbaschi A; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Daw S; Steglich J
Pediatr Radiol; 2024 May; 54(5):725-736. PubMed ID: 38296856
[TBL] [Abstract] [Full Text] [Related]
4. [Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma].
Dourthe ME; Simonin M; Rigaud C; Haouy S; Montravers F; Ducou Le Pointe H; Garnier N; Minard-Colin V; Jo Molina T; Boudjemaa S; Leblanc T; Landman-Parker J
Bull Cancer; 2023 Sep; 110(9):968-977. PubMed ID: 37062647
[TBL] [Abstract] [Full Text] [Related]
5. Lymphoblastic lymphoma: a Concise Review.
Intermesoli T; Weber A; Leoncin M; Frison L; Skert C; Bassan R
Curr Oncol Rep; 2022 Jan; 24(1):1-12. PubMed ID: 35059993
[TBL] [Abstract] [Full Text] [Related]
6. Assessment of Waldeyer's ring in pediatric and adolescent hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-phl-C1 trial.
Kurch L; Mauz-Körholz C; Fosså A; Georgi TW; Kluge R; Bartelt JM; Kunze C; Wohlgemuth WA; Pelz T; Vordermark D; Plößl S; Hasenclever D; Sabri O; Landman-Parker J; Wallace WH; Karlen J; Fernández-Teijeiro A; Cepelova M; Klekawka T; Løndalen AM; Steiner D; Krombach G; Attarbaschi A; Hoffmann M; Ceppi F; Pears J; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Daw S; Körholz D; Stoevesandt D
Pediatr Blood Cancer; 2021 Apr; 68(4):e28903. PubMed ID: 33538093
[TBL] [Abstract] [Full Text] [Related]
7. Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.
Adeleke S; Latifoltojar A; Sidhu H; Galazi M; Shah TT; Clemente J; Davda R; Payne HA; Chouhan MD; Lioumi M; Chua S; Freeman A; Rodriguez-Justo M; Coolen A; Vadgama S; Morris S; Cook GJ; Bomanji J; Arya M; Chowdhury S; Wan S; Haroon A; Ng T; Ahmed HU; Punwani S
BMC Med Imaging; 2019 Nov; 19(1):90. PubMed ID: 31730466
[TBL] [Abstract] [Full Text] [Related]
8. Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric hodgkin lymphoma: Results of the GPOH-HD2002 trial.
Kurch L; Hasenclever D; Kluge R; Georgi T; Tchavdarova L; Golombeck M; Sabri O; Eggert A; Brenner W; Sykora KW; Bengel FM; Rossig C; Körholz D; Schäfers M; Feuchtinger T; Bartenstein P; Ammann RA; Krause T; Urban C; Aigner R; Gattenlöhner S; Klapper W; Mauz-Körholz C
Pediatr Blood Cancer; 2019 Mar; 66(3):e27539. PubMed ID: 30426671
[TBL] [Abstract] [Full Text] [Related]
9.
Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
[TBL] [Abstract] [Full Text] [Related]
10. [LMB chemotherapy for mature B-cell neoplasms in children: a single-center experience].
Osumi T; Mori T; Shioda Y; Kiyotani C; Terashima K; Kato M; Tomizawa D; Ohki K; Kiyokawa N; Iwafuchi H; Yoshioka T; Nakazawa A; Matsumoto K
Rinsho Ketsueki; 2016 Mar; 57(3):346-52. PubMed ID: 27076248
[TBL] [Abstract] [Full Text] [Related]
11. Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in hodgkin's lymphoma.
Kluge R; Chavdarova L; Hoffmann M; Kobe C; Malkowski B; Montravers F; Kurch L; Georgi T; Dietlein M; Wallace WH; Karlen J; Fernández-Teijeiro A; Cepelova M; Wilson L; Bergstraesser E; Sabri O; Mauz-Körholz C; Körholz D; Hasenclever D
PLoS One; 2016; 11(3):e0149072. PubMed ID: 26963909
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-hodgkin's lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract] [Full Text] [Related]
13. Pediatric Nodular Lymphocyte-predominant hodgkin lymphoma: Treatment Recommendations of the GPOH-HD Study Group.
Mauz-Körholz C; Lange T; Hasenclever D; Burkhardt B; Feller AC; Dörffel W; Kluge R; Vordermark D; Körholz D
Klin Padiatr; 2015 Nov; 227(6-7):314-21. PubMed ID: 26356319
[TBL] [Abstract] [Full Text] [Related]
14. [A collaborative study on children with mature B-cell non-hodgkin's lymphoma in China].
; ; ;
Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):649-54. PubMed ID: 25476425
[TBL] [Abstract] [Full Text] [Related]
15. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric hodgkin's lymphoma and non-hodgkin's lymphoma.
Qiu L; Chen Y; Wu J
Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
[TBL] [Abstract] [Full Text] [Related]
16. Roles and limitations of FDG PET in pediatric non-hodgkin lymphoma.
Nakatani K; Nakamoto Y; Watanabe K; Saga T; Higashi T; Togashi K
Clin Nucl Med; 2012 Jul; 37(7):656-62. PubMed ID: 22691506
[TBL] [Abstract] [Full Text] [Related]
17. Extranodal non-hodgkin lymphomas of the oral cavity and maxillofacial region: a clinical study of 58 cases and review of the literature.
Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Gkagkalis A
J Oral Maxillofac Surg; 2012 Dec; 70(12):2776-85. PubMed ID: 22494508
[TBL] [Abstract] [Full Text] [Related]
18. [Role of FDG-PET in staging and Therapy of Children with hodgkin lymphoma].
Kluge R; Körholz D
Klin Padiatr; 2011 Nov; 223(6):315-9. PubMed ID: 22012607
[TBL] [Abstract] [Full Text] [Related]
19. Involved-node radiotherapy in early-stage hodgkin's lymphoma. Definition and guidelines of the German hodgkin Study Group (GHSG).
Eich HT; Müller RP; Engenhart-Cabillic R; Lukas P; Schmidberger H; Staar S; Willich N;
Strahlenther Onkol; 2008 Aug; 184(8):406-10. PubMed ID: 18956517
[TBL] [Abstract] [Full Text] [Related]
20. Lymphoblastic leukaemia and non-hodgkin's lymphoma.
Lilleyman JS; Pinkerton CR
Br Med Bull; 1996 Oct; 52(4):742-63. PubMed ID: 9039729
[TBL] [Abstract] [Full Text] [Related]
[Next]
